Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Chronic Kidney Failure

In brief

Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb. The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring hemodialysis, compared with a marketed phosphate binder, lanthanum carbonate and placebo.

Key facts

Study ID
NCT00841126
Run by
Ineos Healthcare Limited
People needed
657
Starts
2009-07-01
Expected to finish
2011-07-01
Last updated by the study team
2010-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.